Wyatt J R, Vickers T A, Roberson J L, Buckheit R W, Klimkait T, DeBaets E, Davis P W, Rayner B, Imbach J L, Ecker D J
ISIS Pharmaceuticals, Carlsbad, CA 92008.
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1356-60. doi: 10.1073/pnas.91.4.1356.
The phosphorothioate oligonucleotide T2G4T2 was identified as an inhibitor of HIV infection in vitro by combinatorial screening of a library of phosphorothioate oligonucleotides that contained all possible octanucleotide sequences. The oligonucleotide forms a parallel-stranded tetrameric guanosine-quartet structure. Tetramer formation and the phosphorothioate backbone are essential for antiviral activity. The tetramer binds to the human immunodeficiency virus envelope protein gp120 at the V3 loop and inhibits both cell-to-cell and virus-to-cell infection.
通过对包含所有可能八核苷酸序列的硫代磷酸酯寡核苷酸文库进行组合筛选,硫代磷酸酯寡核苷酸T2G4T2在体外被鉴定为HIV感染的抑制剂。该寡核苷酸形成平行链四聚体鸟嘌呤四重奏结构。四聚体的形成和硫代磷酸酯主链对抗病毒活性至关重要。四聚体在V3环处与人免疫缺陷病毒包膜蛋白gp120结合,并抑制细胞间和病毒间感染。